Images (4)

Oroya feverA44.0 - A44.1

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 31.10.2023

Dieser Artikel auf Deutsch

Synonym(s)

Carrión disease; Carrión fever; Peru wart; Verruga peruana

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Carrion 1886; Barton 1909;

DefinitionThis section has been translated automatically.

Biphasic disease caused by Bartonella bacilliformis and occurring only in South America, initially manifesting as acute, severe febrile hemolytic anemia (so-called orya fever), in a later stage as chronic localized or disseminated skin disease with wart-like angiomatous efflorescences reminiscent of Kaposi's sarcoma (verruga peruana or Peru warts). See also Bartonellosis.

PathogenThis section has been translated automatically.

Bartonella bacilliformis is a small, pleomorphic, peritrichous flagellated rod bacterium with marked tropism for human erythrocytes. Transmission by the sand fly Lutzomya verrucarum. Since the sand fly is found exclusively in mountain valleys above 800-3000 m in Peru, Ecuador and Colombia, the disease is also only widespread there.

Occurrence/EpidemiologyThis section has been translated automatically.

Occurrence in Peru, Ecuador, Colombia (in mountain valleys of the Andes located at over 800 m altitude). In endemic areas in Peru 30-45% of the healthy population show antibodies against B. bacilliformis. 40% of the population in endemic areas is affected by either the acute febrile form (Oroya fever) or the chronic verrucous form of the disease (Verruga peruana).

ManifestationThis section has been translated automatically.

2/3 of the diseases occur before the 10th LJ. The majority of the diseases (90%) occur seasonally between January and June.

Clinical featuresThis section has been translated automatically.

Oroya fever: After an incubation period of 15-40 days, high intermittent fever, severe feeling of illness, swelling of lymph nodes, liver and spleen, rapidly progressive hemolytic anemia (due to the decomposition of bacteria-infected erythrocytes).

Verruga peruana: In the second stage of the disease, after overcoming Oroya fever, an eruption of multiple, coarse, red plaques and papules and soft, angiomatous, subcutaneous, 1-2 cm large nodules on the extensor sides of the extremities and on the face appears. These ulcerate easily, transform into papules and finally heal without scarring.

Notice! Oroya fever and Verruga peruana can also occur in isolation.

HistologyThis section has been translated automatically.

Verruga peruana belongs to the bacterially induced lobular hemangiomas. In the late stages it resembles a granuloma pyogenicum with loose stroma and lobularly grouped capillary vessels.

DiagnosisThis section has been translated automatically.

Pathogen detection in the Giemsa-stained blood smear: Numerous bacteria, mostly intraerythrocytic. Cultural cultivation from the blood culture. Pathogen detection in histological sections from skin biopsy.

Complication(s)This section has been translated automatically.

The mortality rate in untreated cases is 5-10%. Complications in untreated cases due to opportunistic pathogens (Mycobacterium tuberculosis, Toxoplasma gondii, Salmonella, Shigella) are occasionally observed.

Internal therapyThis section has been translated automatically.

Start antibiotic therapy immediately if suspected. Treatment with tetracycline (e.g. tetracycline Wolff) 4 times/day 500 mg p.o. or ampicillin (e.g. ampicillin ratiopharm) 3 times/day 0.5-5.0 g i.v. as a short infusion, also penicillin G 4 times/day 1 million IU as a short infusion or streptomycin (e.g. streptomycin Grünenthal) 1 times/day 1 g as a short infusion are effective.

Alternative: Erythromycin (e.g. Erythromycin ratiopharm): 4 times/day 500-1000 mg p.o. or i.v.

Operative therapieThis section has been translated automatically.

In the late stage, operative therapy of the skin changes in order to accelerate the healing process.

ProphylaxisThis section has been translated automatically.

Insect screen.

AftercareThis section has been translated automatically.

After therapy and clinical freedom from symptoms, 10-15% of patients with acute Oroya fever peruana show bacteremia with B. bacilliformis. Herein lies the reservoir for B. bacilliformis.

Note(s)This section has been translated automatically.

Between 1870 and 1890 an unknown epidemic occurred in Peru, affecting mainly railway workers. They suffered from high fever, weakness and anaemia. The disease spread mainly along the new railway line between the capital Lima and the town of La Oroya, which gave it its name. In 1881 a young Peruvian medical student died of the Oroya fever. At the same time he suffered from wartlike skin rashes. A study friend named Alcides Carrion suspected a connection between the fever and the warts. Carrion had the blood of a woman suffering from the rashes inoculated. 22 days later he fell ill with pain, nausea, fever and died some time later from the infection. To this day he is celebrated for his courage as Peru's national hero. The pathogen was first discovered in 1909 by Alberto Barton and was named after him as "Bartonella bacilliformis".

LiteratureThis section has been translated automatically.

  1. Alexander B (1995) A review of bartonellosis in Ecuador and Colombia. At J Trop Med Hyg 52: 354-359
  2. Barton AL (1909) Descripción de elementos endo-globulares hallados en las enfermos de fiebre verrucosa La Crónica médica de Lima 26: 7-10
  3. Bravo F et al (2003) New and re-emerging cutaneous infectious diseases in Latin America and other geographic areas. Dermatol Clin 21: 655-668
  4. Carrion DA (1886) Apuntes sobre la verruga peruana. Posthumous publication, 1886, Clinical studies at the Dos de Mayo hospital in Lima, based on nine cases.
  5. Eremeeva ME et al (2007) Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. N Engl J Med 356: 2381-2387
  6. Garcia-Caceres V et al (1991) Bartnellosis. An immunodepressive disease and the life of Daniel Alcides Carrion. At J Clin Pathol 95: 58-66
  7. Minnick MF et al. (2014) Oroya fever and verruga peruana: bar toneless unique to South America.
    PLoS Negl Trop Dis8:e2919.
  8. Vassallo C et al (2007) Bartonella-related pseudomembranous angiomatous papillomatosis of the oral cavity associated with allogeneic bone marrow transplantation and oral graft-versus-host disease. Br J Dermatol 157: 174-178
  9. Wormser GP (2007) Discovery of new infectious diseases - bartonella species. N Engl J Med 356: 2346-2347

Authors

Last updated on: 31.10.2023

Author: Prof. Dr. med. Peter Altmeyer